INO Insider Trading Activity and SEC Form 4 Filings
INO insider trading summary
No open-market insider purchases or sales of Inovio Pharmaceuticals, Inc. (INO) have been reported on SEC Form 4 in the past 12 months.
Latest INO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 5, 2023 | Lota S. Zoth | Director | Sell | $3K (5,700 @ $0.56) |
| Mar 13, 2023 | David B. Weiner | Director | Sell | $7K (5,833 @ $1.15) |
| Feb 27, 2023 | David B. Weiner | Director | Sell | $15K (11,668 @ $1.28) |
| Aug 11, 2022 | David B. Weiner | Director | Sell | $32K (11,875 @ $2.66) |
| Jul 20, 2022 | Simon X Benito | Director | Sell | $5K (2,000 @ $2.25) |
| May 16, 2022 | Lota S. Zoth | Director | Sell | $7K (3,600 @ $1.98) |
| May 16, 2022 | David B. Weiner | Director | Sell | $18K (9,000 @ $1.95) |
| Mar 16, 2022 | Simon X Benito | Director | Sell | $6K (2,000 @ $3.16) |
| Mar 14, 2022 | David B. Weiner | Director | Sell | $13K (4,083 @ $3.20) |
| Mar 9, 2022 | David B. Weiner | Director | Sell | $14K (4,083 @ $3.33) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.